On behalf of the European Alliance for Access to Safe Medicines, you are kindly invited to join the upcoming virtual roundtable event on "Innovation in nanomedicines: enhancing patient safety through regulatory clarity" which will take place on Monday 30 November 2020 from 11:00 to 12:30 CET.

With the new EU Pharmaceutical Strategy, it is the right time to set the scene for building a pan-European consensus so that regulatory support and enhancements in the field of nanomedicines can be developed further and thus provide medicines with the highest quality, safety and efficacy profiles to European patients. This of course applies to existing medicines but the plethora of new medicines that are in the pipeline.

The virtual event will bring together high-level speakers from the European Parliament, the European Commission, academia and EU health stakeholders with the view to discuss current challenges and provide useful recommendations to address unmet medical needs and enhance quality, safety and efficacy of nanomedicines and nanosimilars by addressing patient safety issues due to significant regulatory challenges across Europe.

Also, the webinar will mark the launch of a comprehensive report on patient safety and nanomedicines on which the EAASM has been working over the past months along with the contribution of several experts organisations.

REGISTER NOW!

We look forward to virtually welcoming you on Monday!

Best wishes,

The EAASM team